SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-19-000310
Filing Date
2019-12-06
Accepted
2019-12-06 13:02:36
Documents
1
Group Members
FOREST BASKETTM. JAMES BARRETTNEA 12 GP, LLCNEA PARTNERS 12, LIMITED PARTNERSHIPPATRICK J. KERINSPETER J. BARRISSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 12, LP - PROTEOSTASIS THERAPEUTICS. SCHEDULE 13D/A(#2) proteo13da_18358.htm SC 13D/A 69913
  Complete submission text file 0001072613-19-000310.txt   71737
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
New Enterprise Associates 12, Limited Partnership (Filed by) CIK: 0001383391 (see all company filings)

IRS No.: 204670653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A | Act: 34 | File No.: 005-89403 | Film No.: 191272538
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences